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Abstract
Purpose To report risk factors, 1-year and overall risk for
a contralateral hip and other osteoporosis-related fractures
in a hip fracture population.
Methods An observational study on 1,229 consecutive
patients of 50 years and older, who sustained a hip fracture
between January 2005 and June 2009. Fractures were
scored retrospectively for 2005–2008 and prospectively for
2008–2009. Rates of a contralateral hip and other osteo-
porosis-related fractures were compared between patients
with and without a history of a fracture. Previous fractures,
gender, age and ASA classification were analysed as pos-
sible risk factors.
Results The absolute risk for a contralateral hip fracture
was 13.8 %, for one or more osteoporosis-related frac-
ture(s) 28.6 %. First-, second- and third-year risk for a
second hip fracture was 2, 1 and 0 %. Median (IQR)
interval between both hip fractures was 18.5 (26.6) months.
One-year incidence of other fractures was 6 %. Only age
was a risk factor for a contralateral hip fracture, hazard
ratio (HR) 1.02 (1.006–1.042, p = 0.008). Patients with a
history of a fracture (33.1 %) did not have a higher inci-
dence of fractures during follow-up (16.7 %) than patients
without fractures in their history (14 %). HR for a contra-
lateral hip fracture for the fracture versus the non-fracture
group was 1.29 (0.75–2.23, p = 0.360).
Conclusion The absolute risk of a contralateral hip frac-
ture after a hip fracture is 13.8 %, the 1-year risk was 2 %,
with a short interval between the 2 hip fractures. Age was a
risk factor for sustaining a contralateral hip fracture; a
fracture in history was not.
Keywords Hip fracture  Contralateral  Bilateral 
Osteoporosis  Risk factors
Introduction
The incidence of osteoporosis has increased over the last
decades in our aging population [1–3]. As advanced age
and osteoporosis lead to enhanced bone fragility and
increased fracture risk, the amount of osteoporosis-related
fractures has also increased. Lifetime risk for developing
an osteoporotic fracture is 30 % with an estimated amount
of 9.0 million fractures worldwide in the year 2000 [4, 5].
Fractures of the proximal femur, distal radius, proximal
humerus and vertebrae are the most frequently seen types
of osteoporosis-related fractures. These fractures are
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related with increased morbidity and mortality. Hip frac-
tures have the most devastating impact on a patients’ life
with 1-year mortality rates of 18 up to 32 %, compared to
15 % after a vertebral fracture [2, 6–8]. Half of all hip
fracture patients will never recover to their pre-fracture
functional capacity and 25 % of these patients reside in a
long-term care institution 1 year after sustaining a hip
fracture [9–11].
Besides high mortality and high morbidity rates, an
osteoporosis-related fracture has been identified as an
important risk factor for sustaining subsequent fractures,
particularly during the first 2 years after the initial fracture
[12, 13]. The risk of sustaining a contralateral hip fracture
within 2 years after the initial hip fracture is reported to be
4–10 % [14, 15]. As hip fractures are the most devastating
fractures for patients, the main goal of this study was to
assess the 1-year risk and absolute risk of sustaining a
contralateral hip fracture in our cohort. Secondary, possible
risk factors for sustaining a contralateral hip fracture were
identified.
Materials and methods
An observational cohort study of 1,229 consecutive hip
fracture patients of 50 years and older, admitted to two
teaching hospitals from January 2005 to July 2009. The
study was retrospective for patients admitted between 2005
and 2008, and prospective for patients admitted between
2008 through June 2009. The first hip fracture sustained
within this time frame was marked as the index hip frac-
ture. Patients with a fracture due to a high-energy trauma or
with a pathologic fracture were excluded. Osteoporosis-
related fractures (contralateral hip, distal radius, proximal
humerus and vertebrae at any level) in the history of all
patients were retrospectively scored. All hospital databases
(emergency department, clinical and radiological records
and operating theatre database) were used to collect frac-
ture data. All admissions of the patients were entered into
our database. When a patient was not admitted to hospital,
emergency room data were still entered into the database.
By combining the digital files of emergency department
admittance, hospital records and operating theatre data all
potential hip and other fractures were scored as complete as
possible.
From the hospital’s records, patient demographics like
age, gender, ASA physical status classification, type of
fracture, type of treatment, type of anaesthesia, were col-
lected onto a case record form (CRF) [16].
Postoperative mortality has been documented by repe-
ated consultation of the population registers present in
every county in The Netherlands. For the assessment of
concomitant fractures both before and after the index hip
fracture, the patients record in the picture and archives
system (PACS) was evaluated from January 2003 (2 years
before the index fracture) up to January 2010. This time
frame was chosen since 2003 a PACS was used in both
hospitals. All low-energy trauma fractures of the contra-
lateral hip, distal radius, proximal humerus and vertebrae at
any level were scored. The patient record files were eval-
uated for notes on previous history for fractures occurred
before 2003. If present, they were recorded at the CRF. As
of 2008 all data were recorded prospectively at the CRF.
The 1-year incidence and prevalence of fractures of the
contralateral hip, distal radius, proximal humerus and
vertebrae both prior to and after the index hip fracture were
determined.
Patients with bilateral hip fractures were compared to
those with a unilateral hip fracture, regarding general
demographics (age, gender, ASA classification, type of
fracture and treatment), prevalence and 1-year incidence of
concomitant fractures. This was done for patients with and
without fractures prior to the index hip fracture. Finally, the
different groups were compared regarding mortality rates.
It was not necessary to obtain approval from the local
ethical committee due to the observational character of this
surveillance study. Therefore, it is an evaluation of usual
care as a part of good clinical practice. Since data could not
be traced back to the individual patient there were no
privacy issues.
Statistical analysis
Categorical data are presented as the number of subjects in
the category, along with the percentages. Chi-square tests
and Fisher’s exact test were used for comparing groups of
categorical data. All continuous data are presented as
means with standard deviations (SD). The independent
Student’s t test was used to compare groups of continuous
data.
Fracture and mortality rates were expressed for dif-
ferent time periods calculated using the Kaplan–Meier
method. Univariable and multivariable Cox regression
analysis was used to calculate the hazard ratios and 95 %
confidence interval (CI) to compare the difference in
mortality and fracture risk in patients with or without
previous fractures. In multivariable analysis the hazard
ratios were adjusted for possible confounders: age, gender
and general condition expressed as the ASA classification
(I/II vs. III/IV).
Combining ASA I or II and III or IV classified patients
in two groups was done as the separate groups of ASA I
(n = 108) and ASA IV (n = 44) classified patients were
too small to be analysed separately.
Age was categorized in three groups: 50–65,
65–85 years and older than 85 years.
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p values lower than 0.05 were considered statistically
significant. All data were analysed in SPSS 18.0 (SPSS Inc.
Chicago, USA).
Results
Characteristics
1,229 hip fracture patients above 50 years were included,
891 female and 338 male. The median follow-up after the
index hip fracture was 17.8 months [interquartile range
(IQR) 28.6]. Mean (SD) age at admission for the index hip
fracture was 81.7 (9.5) years. Women (mean 82.6, SD 9.0)
were older than men (mean 79.4, SD 10.3, p \ 0.001).
The majority of patients were treated with osteosyn-
thesis (60.5 %), followed by (hemi-) arthroplasty (38.1 %).
A small group was treated conservatively (1.4 %).
The overall 1-year mortality rate of the 1,229 patients
was 23 % (95 % CI 21–26 %). More characteristics are
shown in Table 1.
Bilateral hip fractures
169 of the 1,229 patients had bilateral hip fractures, indi-
cating an absolute risk of 13.8 %. The first-, second-, and
third-year risk of a contralateral hip fracture was 2, 1, and
0 %, respectively (Table 2).
Of the 169 patients with bilateral hip fractures, 115
sustained a hip fracture before the index hip fracture, i.e.,
the index fracture was their second hip fracture. In 54
patients the second hip fracture occurred during follow-up
after the index fracture, i.e., the index fracture was the first
hip fracture. The median (IQR) interval between the two hip
fractures in all 169 patients was 18.5 months (26.6), 36.1 %
occurred with 1 year and 61.5 % was sustained in 2 years.
The median (IQR) interval between both hip fractures in
the 54 patients that suffered a contralateral hip fracture
during follow-up was 231 (434) days. As the follow-up of
this group was too short to calculate reliable fracture
incidence ratios, further analysis was performed in the
entire population of 169 patients.
The mean (SD) age of patients at admission for their first
hip fracture in the bilateral hip fractures group was 75.9
(11.5) years. This was lower than the mean (SD) age 81.7
(9.4) years, of the 1,060 unilateral hip fracture patients
(p \ 0.001). The mean (SD) age at time of the second hip
fracture was 82.0 (9.9) years, not different from the uni-
lateral fracture group. The male to female ratio, the mean
age, type of fracture and type of anaesthesia in the uni-
lateral group were equal to the bilateral hip fracture group
(Table 1).
In univariable Cox regression analysis, the hazard ratio
for men versus women to sustain a second hip fracture was
1.15 (0.82–1.62, p = 0.41), for ASA III–IV versus I–II 1.07
(0.76–1.49, p = 0.71), for age per year 1.02 (1.01–1.04,
p = 0.011) and age per decade 1.25 (1.05–1.48, p = 0.011).
In multivariable Cox regression analysis, the hazard
ratio for men versus women for sustaining a contralateral
hip fracture was 1.24 (0.88–1.75, p = 0.22), for ASA
Table 1 Characteristics of
unilateral and bilateral hip
fracture patients and results of
the univariable Cox regression
analysis
Female gender and ASA I–II are
reference categories
HR Hazard ratio, CI confidence
interval, IQR interquartile
range, ASA American society of
anesthesiologists physical status
classification
* Mann–Whitney test
# t test
Study
population
N (%)
Unilateral
hip fracture
N (%)
Bilateral
hip fracture
N (%)
HR (CI) p value
Median (IQR) follow-up
in days
1,229 (100) 1,060 (86.2) 169 (13.8)
543 (873) 536 (886) 563 (810) 0.81*
Gender
Female 891 (72.5) 768 (72.5) 123 (72.8) 1.15 (0.82–1.62) 0.41
Male 338 (27.5) 292 (27.5) 46 (27.2)
Age, mean (SD) 81.7 (9.5) 81.7 (9.4) 82.0 (9.9) 0.74#
Age HR per year 1.02 (1.01–1.04) 0.011
Age HR per decade 1.25 (1.05–1.48) 0.011
ASA classification
I–II 849 (69.1) 727 (68.6) 122 (72.2) 1.07 (0.76–1.49) 0.71
III–IV 380 (30.9) 333 (31.4) 47 (27.8)
Fracture type
Neck of femur 704 (57) 617 (58) 87 (51.5)
(Inter) trochanteric 485 (39) 412 (39) 73 (43.2)
Subtrochanteric 40 (3) 31 (3) 9 (5.3) 0.11
Anaesthesia
Spinal 1,129 (92) 1,032 (92) 97 (91)
General 83 (7) 75 (7) 8 (7) 0.94
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III–IV versus I–II 0.98 (0.69–1.38, p = 0.90), for age per
year 1.02 (1.01–1.04, p = 0.008) and age per decade 1.27
(1.06–1.51, p = 0.008).
Concomitant osteoporosis-related fractures and risk
factors
In 407 patients (33.1 %) an osteoporosis-related fracture
prior to the index hip fracture was found. This group of 407
was compared to the 821 patients who did not suffer
fractures prior to the index event.
The absolute risk of a contralateral hip fracture during
follow-up in the group with fractures was 5.1 % (n = 21)
and in the group without fractures 4.0 % (n = 33). The
1-year risk for a contralateral hip fracture for the prior
fracture versus the non-prior fracture group was 3.0 versus
2.0 %. In univariable Cox regression analysis the hazard
ratio for sustaining a contralateral hip fracture for the
fracture versus the non-fracture group was 1.29 (0.75–2.23,
p = 0.36).
The absolute risk of sustaining an osteoporosis-related
fracture in the population without fractures in their medical
history was 14.0 % with a 1-year risk of 9 %. In the group
that did sustain prior fractures, the absolute risk was
16.7 % and the 1-year risk 9 %. In univariable Cox
regression analysis the hazard ratio for sustaining an
osteoporosis-related fracture in the population with frac-
tures in their medical history versus the population without
fractures in their medical history was 1.19 (0.88–1.61,
p = 0.25).
The risks of sustaining different osteoporosis-related
fractures after previous sustained fractures are listed in
Table 3. A previous fracture was only a significant risk
factor for sustaining a distal radius fracture (HR 1.66,
1.07–2.59, p = 0.025).
The 1-year risk after the index fracture for osteoporosis-
related fractures was 9 % in both women and men and 4 %
in both men and women in the second year. In univariable
Cox regression analysis, the hazard ratio for sustaining an
osteoporosis-related fracture for male gender versus female
was 0.95 (0.68–1.31, p = 0.74).
The absolute risk of sustaining osteoporosis-related
fractures after the index hip fracture was 15.9 % for ASA
I/II and 12.6 % for ASA III/IV classified patients. The
1-year risk of osteoporotic fractures was 9 % for ASA I/II
versus 8 % in ASA III/IV. In univariable Cox regression
analysis the hazard ratio for sustaining an osteoporosis-
related fracture for ASA III–IV versus ASA I–II was 0.79
(0.57–1.09, p = 0.15).
No differences were seen in fracture risks in different
age categories. More characteristics of the different age
groups are shown in Table 4.
Mortality
The 1-year mortality risk and hazard ratios for mortality for
the age categories, gender, ASA classification, the occur-
rence of a bilateral hip fracture, a fracture in the history, a
fracture during follow-up and a hip fracture during follow-up
are presented in Table 5. The hazard ratios for mortality were
significantly higher for the age categories 65–85 years and
older than 85 years, male gender and ASA III–IV, but not for
the occurrence of a bilateral hip fracture, a fracture in the
history and not for having a (hip) fracture during follow-up
compared with the reference categories.
Discussion
Our main goal was to describe the 1-year risk and absolute
risks of sustaining a subsequent second hip fracture and other
osteoporosis-related fractures in a hip fracture cohort. The
absolute risk of a contralateral hip fracture was 13.8 %, the
1 year risk 2 %, for the other osteoporosis-related fractures
this was 28.6 and 6 %, respectively. The median interval
Table 2 Absolute risk and risk per year after the index fracture (both
in %) for a subsequent (hip) fracture and for mortality during follow-
up
Absolute
risk
Year
1
Year
2
Year
3
Year
4
Subsequent fracture
risk
28.6 6 3 1 1
Subsequent hip
fracture risk
13.8 2 1 0 0
Mortality risk 36.0 23 11 10 11
Table 3 One-year risks (in %)
for different osteoporosis-
related fractures for the
population with and without
previous fractures
HR hazard ratio, CI confidence
interval
With previous fractures Without previous fractures HR (CI) p value
N % One-year risk N % One-year risk
Hip 21 5.1 3.0 33 4.0 2.0 1.29 (0.75–2.23) 0.36
Distal radius 36 8.8 2.0 43 5.2 2.0 1.66 (1.07–2.59) 0.025
Humerus 20 4.9 2.0 32 3.9 1.0 1.27 (0.72–2.21) 0.41
Vertebrae 42 10.3 2.0 69 5.0 3.0 1.22 (0.83–1.79) 0.32
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between the first and the second hip fracture was rather short,
18.5 months. The risk of a new osteoporosis-related fracture
was not higher in patients with a fracture in their medical
history than in those that did not.
Our second goal was to describe independent risk fac-
tors for sustaining a subsequent second hip fracture. We
compared the population with a bilateral hip fracture with
the unilateral population. There was no difference between
patient’s gender distribution, ASA classification, and type
of fracture or mortality rate between the uni- and bilateral
hip fractures population. A higher age was the only risk
factor that could be identified for sustaining a contralateral
hip fracture.
Providing reliable concomitant fracture incidence rates
and identifying risk factors in hip fracture patients can help
in decision-making policies for fracture prevention, like
osteoporosis prophylaxis. Furthermore, more accurate
information about the future can be provided to both
patient and family with respect to be expected fractures.
In our population, the 1-year risk of a second hip fracture
was 2.0 %. Lawrence et al. [17] found in their recent study of
a large cohort of 6,331 patients a comparable 1 year inci-
dence of 2.7 %. Other prospective studies found the same
incidence of around 2 % [18, 19]. However, Lo¨nnroos et al.
[14] found a higher contralateral hip fracture incidence of
5 %. The fact that they analysed a smaller population (501
patients) might account for the difference. Overall, 28.6 % of
our patients had one or more osteoporosis-related fractures in
our cohort. This resembles the lifetime risk for developing an
osteoporotic fracture as reported by Klotzbuecher and
Cummings [2, 4]. Our 1- and 2-year risk for other osteopo-
rosis-related fractures were 6 and 3 %. This resembles the
figures reported by van Helden et al. [13] who found a
cumulative incidence of 10.8 % after 2 years follow-up.
Although female gender is described as a risk factor in many
studies, our cohort did not support this suggestion [3, 9, 20].
Rates of successive fractures after admission for a hip frac-
ture were also not significantly higher in patients with prior
fractures compared to those without. We found that a pre-
vious fracture was only a risk factor for sustaining a distal
radius fracture in the future, not for other types of fractures.
This is contrary to other series that reported a previous
fracture at any site to be a significant risk factor for a future
fracture. This might be explained by our retrospective col-
lecting of data of previous fractures, accounting for a pos-
sible loss of fractures. A limitation is the potential loss of
fractures in the retrospective review of medical charts. This
might have led to an underestimation of fracture rates, thus
influencing the calculated risk factors.
A multivariable Cox regression analysis on risk factors
for a contralateral hip fracture showed only a significant
Table 4 Fractures in history and one-year (hip) fracture risk for three age categories
Age
(years)
N (% of total
population)
Fractures in
history N (%)
One-year contralateral
hip fracture risk (%)
HR (CI) p value One-year
fracture risk (%)
HR (CI) p value
50–65 87 (7.1) 23 (5.6) 3 11
65–85 633 (51.5) 206 (50.5) 2 0.57 (0.23–1.39) 0.21 9 0.97 (0.56–1.70) 0.92
[85 509 (41.4) 179 (43.9) 3 0.65 (0.27–1.60) 0.35 8 0.85 (0.48–1.51) 0.57
Age group 50–65 was used as reference category
HR hazard ratio, CI confidence interval
Table 5 Mortality for age categories, gender, ASA classification, for
patients with or without bilateral hip fractures, a fracture in the his-
tory, a fracture during follow-up and a hip fracture during follow-up
N (% of
population)
One-year
mortality
(%)
HR (CI) for
mortality
p value
Age categories (years)
50–65 87 (7.1) 3
65–85 633 (51.5) 20 5.24 (2.33–11.81) \0.001
[85 509 (41.4) 33 9.10 (4.05–20.47) \0.001
Gender
Female 891 (72.5) 23
Male 338 (27.5) 26 1.23 (1.00–1.51) 0.046
ASA
I–II 849 (69.1) 20
III–IV 380 (30.9) 33 1.94 (1.61–2.35) \0.001
Bilateral hip fracture
No 1,060 (86.2) 25
Yes 169 (13.8) 19 0.76 (0.57–1.03) 0.073
Fracture in history
No 821 (66.8) 24
Yes 408 (33.2) 24 0.88 (0.72–1.08) 0.22
Fracture during FU
No 1,046 (85.1) 25
Yes 183 (14.9) 21 0.91 (0.70–1.18) 0.47
Hip fracture during FU
No 1,175 (95.6) 24
Yes 54 (4.4) 19 0.87 (0.55–1.38) 0.56
Age 50–65, female gender and ASA I–II are reference categories
HR hazard ratio, CI confidence interval, FU follow-up, ASA American
Society of Anesthesiologists physical status classification
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influence of age, not of gender and ASA classification. This
is an expected outcome; the more years lived, the more risk
to sustain a fracture.
Patient’s characteristics of the entire population and the
bilateral hip fracture population were comparable. How-
ever, patients admitted for a second hip fracture did sustain
their first hip fracture on a significant lower age than
patients admitted for their first hip fracture (75.9 vs.
81.7 years, p \ 0.001). Therefore, it might be good prac-
tice to screen patients who sustain their first hip fracture at
a younger age thoroughly for osteoporosis and other risk
factors.
The median (IQR) interval between the two hip fractures
in all 169 patients was 18.5 months (26.6), 36.1 % occur-
red with 1 year and 61.5 % was sustained in 2 years.
Nymark [21] (9,990 patients) showed that 50 % of the
contralateral hip fractures occurred within 12 months in
men, and within 19 months in women. Other reported
mean intervals between two hip fractures differ from
2.1 years (Chevally, 4,115 patients), 2.3 years (Kok, 1,604
patients), 3.3 years (Schroder, 3,898 patients) to 4.3 years
(Fukushima 835 patients) [22–25]. The latter reported more
that 70 % of all contralateral hip fractures to occur within
5 years, resembling our findings [25]. Therefore, the
interval between two hip fractures is relatively short.
Therefore, the interval between two hip fractures is rela-
tively short. The effectiveness of osteoporosis medication
is high, with relatively early results; commonly used
osteoporosis agents like risedronate and alendronate sig-
nificantly reduce the incidence of non-vertebral fractures
(21–39 %) compared to placebo during 3 or more years of
follow-up [26–31]. In post hoc analyses of these trial data,
the reduction of non-vertebral fractures was present at
6 months for 5 mg daily dosing of risedronate [32] and at
12 months for 10 mg daily dosing of alendronate [33] or
24 months for 5 mg daily dosing of alendronate [26, 34].
These findings emphasize the importance of early
screening for osteoporosis after a fracture; starting osteo-
porosis medication can prevent subsequent fractures in the
future.
We presented a large series on hip fracture patients with
a median follow-up of 2 years. The main limitation of our
study was the retrospective collection of a part of the
fracture patient data. This might potentially have led to an
underestimation of the incidence of fracture from the
medical chart. Although in this retrospective part of the
study we vigorously analysed all radiographs and patient
charts for presence of fractures after the index hip fracture,
thus minimizing this potential error of underestimating
fracture incidence. Furthermore, the reported fracture rates
are comparable to a recent Dutch study [13]; therefore, the
level of underestimation of the incidence of fractures might
be low. Another limitation is the lack of data on bone
mineral density; the actual number of patients suffering
from osteoporosis is unknown. Finally, no data on the start
of osteoporosis medication after the index fracture were
available. This could have influenced the fracture rates
during follow-up.
In conclusion, this large series adds important infor-
mation to existing literature on hip fracture incidence rates
and identifies risk factors. It emphasizes the importance of
osteoporosis screening and treatment to prevent subsequent
fractures because of the good and early effectiveness of
current osteoporosis medication. Our outcomes can be used
as a baseline for evaluating the efficacy of present osteo-
porosis screening and treatment modalities for successive
fracture rates.
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